E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1109-1114

  Nuruki, Kensuke ^a   Toyoyama, Hironobu ^a   Ueno, Shinichi ^a   Hamanoue, Masahiro ^a   Tanabe, Gen ^a   Aikou, Takashi ^a   Ozawa, Masayuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

E cadherin; N cadherin; Plakoglobin; catenin; catenin

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CALCIUM ION; CATENIN; COMPLEMENTARY DNA; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; UVOMORULIN;

ARTICLE; CELL ADHESION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0031877964     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1109     Document Type: Article

References (50)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
2. Kemler R: From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-321, 1993.
3. Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102: 639-655, 1988.
4. Ozawa M, Baribault H and Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717, 1989.
5. Knudsen KA and Wheelock MJ: Plakoglobin, or an 83-kD homologue distinct from β-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol 118: 671-679, 1992.
6. Ozawa M, Ringwald M and Kemler R: Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 87: 4246-4250, 1990.
7. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S and Takeichi M: Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 70: 293-301, 1992.
8. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W and Funke I: E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53: 1690-1695, 1993.
9. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
10. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM and Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53: 3241-3245, 1993.
11. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM and Isaacs WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52: 5104-5109, 1992.
12. Dorudi S, Sheffield JP, Poulsom R, Northover JM and Hart IR: E-cadherin expression in colorectal cancer. An immuno-cytochemical and in situ hybridization study. Am J Pathol 142: 981-986, 1993.
13. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y. Matsuyoshi N, Hirano S, Takeichi M and Mon T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993.
14. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993.
15. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS and Millis RR: Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169: 245-250, 1993.
16. Ochiai A, Akimoto S, Shimoyama Y, Nagafuchi A, Tsukita S and Hirohashi S: Frequent loss of a catenin expression in sirrhous carcinomas with scattered cell growth. Jpn J Cancer Res 85: 266-273, 1994.
17. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, Tsukita S and Mori T: E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54: 291-296, 1994.
18. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamuram S, Inoue M, Monden T, Ito F and Monden M: β-catenin expression in human cancers. Am J Pathol 148: 39-46, 1996.
19. Shimoyama Y and Hirohashi S: Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 57: 131-135, 1991.
20. Yamaoka K, Nouchi T, Tazawa J, Hiranuma S, Marumo F and Sato C: Expression of gap junction protein connexin 32 and E-cadherin in human hepatocellular carcinoma. J Hepatol 22: 536-539, 1995.
21. Ihara A, Koizumi H, Hashizume R and Uchikoshi T: Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23: 1441-1447, 1996.
22. Tsutsui J, Moriyama M, Arima N, Ohtsubo H, Tanaka H and Ozawa M: Expression of cadherin-catenin complexes in human leukemia cell lines. J Biochem (In press).
23. Mansouri A, Spurr N, Goodfellow PN and Kemler R: Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 38: 67-71, 1988.
24. Ozawa M, Terada H and Pedraza C: The fourth armadillo repeat of plakoglobin (γ-catenin) is required for its high affinity binding to the cytoplasmic domains of E-cadherin and desmosomal cadherin Dsg2, and the tumor suppressor APC protein. J Biochem 118: 1077-1082, 1995.
25. Hatta K, Nose A, Nagafuchi A and Takeichi M: Cloning and expression of cDNA encoding a neural calcium-dependent cell adhesion molecule: its identity in the cadherin gene family. J Cell Biol 106: 873-881, 1988.
26. Linnemann D, Gaardsvoll H, Dalseg AM, Zhernosekov D, Lundgren T, Edvardsen K and Bock E: Characterization of N-cadherin messenger RNA and polypeptide expression in rat. Int J Dev Neurosci 12: 441-450, 1994.
27. Salomon D, Ayalon O, Patel-King R, Hynes RO and Geiger B: Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 102: 7-17, 1992.
28. Kozyraki R, Scoazec JY, Flejou JF, D'Errico A, Bedossa P, Terris B. Fiorentino M, Bringuier AF, Grigioni WF and Feldmann G: Expression of cadherins and α-catenin in primary epithelial tumors of the liver. Gastroenterology 110: 1137-1149, 1996.
29. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
30. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T and Hirohashi S: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862, 1994.
31. Kanai Y, Oda T, Tsuda H, Ochiai A and Hirohashi S: Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 85: 1035-1039, 1994.
32. Berx G, Cleton-Jansen AM, Strumane K. de-Leeuw WJ, Nollet F, van Roy F and Cornelisse C: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13: 1919-1925, 1996.
33. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S and Hirohashi S: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 52: 5770-5774, 1992.
34. Oda T, Kanai Y, Shimoyama Y, Nagafuchi A, Tsukita S and Hirohashi S: Cloning of the human α-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem Biophys Res Commun 193: 897-904, 1993.
35. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F, Takeichi M, Matsuda H and Hirohashi S: A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54: 6282-6287, 1994.
36. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N and Niitsu Y: Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175-1181, 1995.
37. Candidus S, Bischoff P, Becker KF and Hofler H: No evidence for mutations in the α- and β-catenin genes in human gastric and breast carcinomas. Cancer Res 56: 49-52, 1996.
38. Nagafuchi A, Takeichi M and Tsukita S: The 102 kD cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell 65: 849-857, 1991.
39. Kowalczyk AP, Palka HL, Luu HH, Nilles LA, Anderson JE, Wheelock MJ and Green KJ: Posttranslational regulation of plakoglobin expression. Influence of the desmosomal cadherins on plakoglobin metabolic stability. J Biol Chem 269: 31214-31223, 1994.
40. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG and Dejana E: Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem 270: 30965-30972, 1995.
41. Herrenknecht K, Ozawa M, Eckerskorn C, Lottspeich F, Lenter M and Kemler R: The uvomorulin-anchorage protein a catenin is a vinculin homologue. Proc Natl Acad Sci USA 88: 9156-9160, 1991.
42. Ozawa M and Kemler R: Molecular organization of the uvomorulin-catenin complex. J Cell Biol 116: 989-996, 1992.
43. Knudsen KA and Wheelock MJ: Plakoglobin, or an 83-kD homologue distinct from β-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol 118: 671-679, 1992.
44. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S and Polakis P: Association of the APC gene product with β-catenin. Science 262: 1731-1734, 1993.
45. Su LK, Vogelstein B and Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737, 1993.
46. Shibata T, Gotoh M, Ochiai A and Hirohashi S: Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. Biochem Biophys Res Commun 203: 519-522, 1994.
47. Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P: Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050, 1995.
48. cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein α-catenin. Mol Cell Biol 15: 4819-4824, 1995.
49. Inomata M, Ochiai A, Akimoto S, Kitano S and Hirohashi S: Alteration in β-catenin expression in colonic epithelial cells of familial adnomatous polyposis patients. Cancer Res 56: 2213-2217, 1996.
50. Davis LM, Caspary WJ, Sakallah SA, Maronpot R, Wiseman R, Barrett JC, Elliott R and Hozier JC: Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis 15: 1637-1645, 1994.